Alterations of the retinoblastoma a susceptibility gene in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 18, Issue 5-6, 1995, Pages 399-404

  Neubauer, Andreas ^a   Richiero, Kecia ^a   Huhn, Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic lymphocytic leukemia; Retinoblastoma susceptibility gene

Indexed keywords

CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RETINOBLASTOMA; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 13; DNA, NEOPLASM; GENE EXPRESSION; GENES, RETINOBLASTOMA; HUMAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MUTATION; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T;

EID: 0029082788     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199509059637     Document Type: Article

References (44)

1. Cellular oncogenes and retroviruses
2. Isolation of a transforming sequence from a human bladder carcinoma cell line
3. Tumor suppressor genes
4. Complementation of the tumorigenic phenotype in human cellhybrids
5. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor
6. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase
7. A novel putative tyrosine kinase receptor with oncogenic potential
8. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
9. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor
10. BCL-2 initiates a new cytegory of oncogenes: regulators of cell deaths
11. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
12. Clinical implications of the p53 tumor-suppressor gene
13. Chromosome abnormalities involving band 13q 14 in hematologic malignancies
14. Prognostic subgroups in B cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities
15. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia
16. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics
17. Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors
18. Point mutational incativation of the retinoblastoma antioncogene
19. Oncogene rearrangements in chronic B-cell leukemia
20. Inactivation of the retinoblastoma gene in human lymphoid malignancies
21. Use of a retinoblastoma gene probe to investigate clonality in Richter' s syndrome
22. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia
23. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus
24. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q 14 defines the location of a gene critical in leukemogenesis in chronic B-cell lymphocytic leukemia
25. The consistent 13q14 translocation breakpoints seen in B-cell leukemia (B-CLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene
26. Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone
27. Mutation and cancer: Statistical study of retinoblastoma
28. Oncogenic point mutations in the human retinoblastoma gene: Their application to genetic counseling
29. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression
30. Altered expression of the retinoblastoma gene product in human sarcomas
31. Altered expression of the retinoblastoma susceptibility and gene in chronic. lymphocytic leukemia
32. The retinoblastoma susceptibility gene product undergoes cell-cycle dependent dephosphorylation and binding to and release from SV40 large T
33. The E2F transcription factor is a cellular target for the RB protein
34. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
35. Retinoblastoma protein switches the E2F site from positive to negative element
36. Amino-terminal domains of c-myc and N-myc proteins mediated binding to the retinoblastoma gene product
37. Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RBI
38. Retinoblastoma gene mutations in human cancer
39. Cyclin D1 expression is regulated by the retinoblastoma protein
40. The Rb gene suppresses the growth of normal cells
41. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts
42. The retinoblastoma gene: role in cell cycle control and cell differentiation
43. For our eyes only
44. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells